Ray Dalio’s Opko Health OPK Stock Holding History

Ray Dalio’s Portfolio OPK Stock Details OPK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-54,338	Closed	-$67.9K	–	847
2022 Q4	$67.9K	Buy	54,338 +41,129	+311%	+$64.8K	﹤0.01%	819
2022 Q3	$25K	Buy	+13,209	New	+$31.2K	﹤0.01%	866

Other funds holding OPK

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Ray Dalio's OPK Position: Q1 2023 in Review

Ray Dalio sold out of Opko Health (OPK) in Q1 2023, closing a stake of 54,338 shares — an estimated $67.9K sold.

Ray Dalio first reported a position in OPK in Q3 2022 and held it in 2 quarters. The position peaked at $67.9K in Q4 2022. 227 funds tracked by Wall St. Rank hold OPK as of Q1 2023.

Ray Dalio reported no remaining Opko Health position as of Q1 2023 after selling out during the quarter.
Ray Dalio sold 54,338 Opko Health shares in Q1 2023, an estimated $67.9K.
Ray Dalio first reported a position in Opko Health in Q3 2022 and held it in 2 quarters.
Ray Dalio's Opko Health position peaked at $67.9K in Q4 2022.
227 funds tracked by Wall St. Rank held Opko Health as of Q1 2023.

Based on Bridgewater Associates's 13F filing for Q1 2023, filed 12 May 2023.